Botulinum Toxin for Shoulder Pain: A Cochrane Systematic Review

Singh, Jasvinder A.; Fitzgerald, Patrick M

doi:10.3899/jrheum.101081

Cited by 28 publications

(29 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a systematic review performed by Singh and Fitzgerald (2011), five RCTs in patients with HSP found that an intramuscular injection of BoNT/A significantly reduced pain at 3Y6 months and improved shoulder external rotation at 1 month. The work of Teasell, Foley, Pereira, Sequeira, and Miller (2012) concluded that botulinum toxin injected into the subscapularis muscle could reduce spastic shoulder pain and improve passive range of motion of the hemiplegic shoulder.…”

Section: Pharmacologic Therapiesmentioning

confidence: 98%

Current Evidence in the Management of Poststroke Hemiplegic Shoulder Pain

Alexander

2015

Journal of Neuroscience Nursing

View full text Add to dashboard Cite

Hemiplegic shoulder pain is a common, complex, and distressing complication, which is related to stroke and occurs in the paralytic side of the patient. It not only presents in the early stage but also can persist into the chronic stage of stroke. The incidence of this complication varies from 12% to 58%, and the most common period of occurrence is at 8-10 weeks poststroke. The multifactorial etiology and underlying mechanisms make it intractable. It is difficult to get a clear description of the percentage of patients receiving adequate pain relief because of a large number of treatments and different results found in interventional studies performed in subjects in different stages of stroke. This review summarizes the incidence, temporal presentation, and etiology of hemiplegic shoulder pain and the current advances in its management and analyzes the reliability and validity of the studies. It suggests careful and regular assessment, and an integrated care model is necessary in practice.

show abstract

Section: Pharmacologic Therapiesmentioning

confidence: 98%

Current Evidence in the Management of Poststroke Hemiplegic Shoulder Pain

Alexander

2015

Journal of Neuroscience Nursing

View full text Add to dashboard Cite

show abstract

“…Анализ исследова-ний применения БТА при постинсультной боли в плече показал значительное и достоверное снижение боли. В предыдущем систематическом обзоре 2011 г. было также подтверждено, что БТA уменьшает боль и улучшает функцию плеча у пациентов, страдающих хронической болью в плече после спастической гемиплегии или артрита [60]. Однако авторы делают вывод, что для под-тверждения эффективности нейротоксина при данной патологии необходимы дополнительные широкомас-штабные многоцентровые РКИ, поскольку все исследова-ния проводились на небольшом количестве пациентов.…”

Section: особенности клинического проявления антиноцицептивного эффекunclassified

Botulinum Toxin for Pain Syndromes

Костенко¹,

Коновалова²,

Orlova³

et al. 2018

Med. sov.

View full text Add to dashboard Cite

“…However, recent research has revealed likely additional antinociceptive properties of the toxin. 30 Botulinum toxin A provides another therapeutic option for clinicians to treat patients with shoulder pain at little additional risk to the patient. 26--28 Several studies have examined the potential beneficial effects of the toxin.…”

Section: Injectionsmentioning

confidence: 99%

Biologic treatments for shoulder pain

Varthi

Piposar

Chan

et al. 2013

Current Orthopaedic Practice

View full text Add to dashboard Cite

Shoulder pain is a common musculoskeletal complaint that can result from a variety of pathologic processes, including arthritis, bursitis and rotator cuff disease. Physicians often initiate treatment of shoulder pain with oral medications and progress to injectable medications for patients with more severe pain. Several promising new therapies for shoulder pain have emerged in recent years. These treatment modalities, which include cytokines, growth factors, platelet rich plasma, and stem cells, could provide physicians with powerful medications to treat patients with severe shoulder pain. This article provides a review of the biologic treatments available to physicians treating patients with shoulder pain and highlights some of the research and newest developments in the use of cytokines, growth factors, platelet rich plasma and stem cells for shoulder pathology.

show abstract

Botulinum Toxin for Shoulder Pain: A Cochrane Systematic Review

Abstract: With evidence from few studies with small sample sizes and medium to high risk of bias, botulinum toxin type A injections decreased pain and improved shoulder function in patients with chronic shoulder pain due to spastic hemiplegia or arthritis.

Cited by 28 publications

References 53 publications

Current Evidence in the Management of Poststroke Hemiplegic Shoulder Pain

Current Evidence in the Management of Poststroke Hemiplegic Shoulder Pain

Botulinum Toxin for Pain Syndromes

Biologic treatments for shoulder pain

Contact Info

Product

Resources

About